High-performance liquid chromatographic assay for cytosine arabinoside, uracil arabinoside and some related nucleosides
- 1 January 1983
- journal article
- research article
- Published by Elsevier BV in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 274 (MAY), 87-93
- https://doi.org/10.1016/s0378-4347(00)84411-4
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Effects of high-dose cytarabineCancer Cell, 1982
- The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemia.British Journal of Clinical Pharmacology, 1981
- High dose cytosine arabinoside (HDARAC) in refractory acute leukemiaCancer, 1979
- Pharmacologic studies of continuous infusion of arabinosylcytosine by liquid infusion systemClinical Pharmacology & Therapeutics, 1977
- Pharmacokinetics of cytosine arabinoside in acute myeloid leukemiaClinical Pharmacology & Therapeutics, 1977
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineCancer Cell, 1971
- Cytosine arabinoside in acute granulocytic leukemiaClinical Pharmacology & Therapeutics, 1971
- Transport and Phosphorylation as Factors in the Antitumor Action of Cytosine ArabinosideScience, 1967
- Biochemical and pharmacological studies with 1-β-d-arabinofuranosylcytosine in manBiochemical Pharmacology, 1966
- Studies of the enzymatic deamination of cytosine arabinoside—I: Enzyme distribution and species specificityBiochemical Pharmacology, 1965